{"entity":{"type":"insider","cik":"0001571211","url":"/insider/0001571211","json_url":"/insider/0001571211.json","name":"Luly Jay R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":18,"first":"2014-01-03","last":"2025-12-05","span_basis":"filed_date"},"name_variants":[{"name":"Luly Jay R.","source":"filing","n_filings":18,"first_seen":"2014-01-03","last_seen":"2025-12-05"}],"transactions":[{"id":4973969,"accession":"0002064832-25-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002064832-25-000057","line_url":"/filing/0002064832-25-000057#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4743.0,"shares_display":"4,743","price_per_share":14.23,"price_display":"14.23","price_state":"stated","total_value":67492.89,"total_display":"67,492.89","total_whole":"67,493","shares_owned_after":858026.0,"shares_owned_after_display":"858,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider"},{"id":4167035,"accession":"0001062993-25-002225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-002225","line_url":"/filing/0001062993-25-002225#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":5.69,"price_display":"5.69","price_state":"stated","total_value":256050.0,"total_display":"256,050.00","total_whole":"256,050","shares_owned_after":846638.0,"shares_owned_after_display":"846,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-12","scope":"insider"},{"id":3116196,"accession":"0001062993-24-020375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-020375","line_url":"/filing/0001062993-24-020375#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5142.0,"shares_display":"5,142","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":41444.52,"total_display":"41,444.52","total_whole":"41,445","shares_owned_after":801638.0,"shares_owned_after_display":"801,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-10","scope":"insider"},{"id":8751607,"accession":"0001062993-23-022045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-022045","line_url":"/filing/0001062993-23-022045#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7230.0,"shares_display":"7,230","price_per_share":9.63,"price_display":"9.63","price_state":"stated","total_value":69624.9,"total_display":"69,624.90","total_whole":"69,625","shares_owned_after":806793.0,"shares_owned_after_display":"806,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8531946,"accession":"0001062993-23-006867","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-23-006867","line_url":"/filing/0001062993-23-006867","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27912.0,"shares_display":"27,912","price_per_share":45.164385927199774,"price_display":"45.16","price_state":"stated","total_value":1260628.34,"total_display":"1,260,628.34","total_whole":"1,260,628","shares_owned_after":821376.0,"shares_owned_after_display":"821,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-14","scope":"insider","n_lines":3},{"id":6676792,"accession":"0001062993-22-024037","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-024037","line_url":"/filing/0001062993-22-024037","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":44.72376166666667,"price_display":"44.72","price_state":"stated","total_value":1341712.85,"total_display":"1,341,712.85","total_whole":"1,341,713","shares_owned_after":773805.0,"shares_owned_after_display":"773,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-16","scope":"insider","n_lines":3},{"id":5451437,"accession":"0001177648-21-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001177648-21-000025","line_url":"/filing/0001177648-21-000025#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4516.0,"shares_display":"4,516","price_per_share":59.0562,"price_display":"59.06","price_state":"stated","total_value":266697.7992,"total_display":"266,697.80","total_whole":"266,698","shares_owned_after":676972.0,"shares_owned_after_display":"676,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":5985416,"accession":"0001177648-18-000030","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001177648-18-000030","line_url":"/filing/0001177648-18-000030","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32023.0,"shares_display":"32,023","price_per_share":125.37525524779065,"price_display":"125.38","price_state":"stated","total_value":4014891.7988,"total_display":"4,014,891.80","total_whole":"4,014,892","shares_owned_after":612427.0,"shares_owned_after_display":"612,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-09","scope":"insider","n_lines":4},{"id":5985405,"accession":"0001177648-18-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001177648-18-000030","line_url":"/filing/0001177648-18-000030#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2977.0,"shares_display":"2,977","price_per_share":123.8051,"price_display":"123.81","price_state":"stated","total_value":368567.7827,"total_display":"368,567.78","total_whole":"368,568","shares_owned_after":625049.0,"shares_owned_after_display":"625,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-09","scope":"insider"},{"id":6789460,"accession":"0001177648-18-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001177648-18-000026","line_url":"/filing/0001177648-18-000026#line-2","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10968.0,"shares_display":"10,968","price_per_share":105.8299,"price_display":"105.83","price_state":"stated","total_value":1160742.3432,"total_display":"1,160,742.34","total_whole":"1,160,742","shares_owned_after":628026.0,"shares_owned_after_display":"628,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-18","scope":"insider"},{"id":6789454,"accession":"0001177648-18-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001177648-18-000026","line_url":"/filing/0001177648-18-000026#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14032.0,"shares_display":"14,032","price_per_share":105.8233,"price_display":"105.82","price_state":"stated","total_value":1484912.5456,"total_display":"1,484,912.55","total_whole":"1,484,913","shares_owned_after":638994.0,"shares_owned_after_display":"638,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-18","scope":"insider"},{"id":8765772,"accession":"0000908662-15-000119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000908662-15-000119","line_url":"/filing/0000908662-15-000119","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":33.36804466666667,"price_display":"33.37","price_state":"stated","total_value":500520.67,"total_display":"500,520.67","total_whole":"500,521","shares_owned_after":480093.0,"shares_owned_after_display":"480,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-10","scope":"insider","n_lines":3},{"id":8593833,"accession":"0000908662-15-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908662-15-000084","line_url":"/filing/0000908662-15-000084#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":35.3526,"price_display":"35.35","price_state":"stated","total_value":530289.0,"total_display":"530,289.00","total_whole":"530,289","shares_owned_after":491393.0,"shares_owned_after_display":"491,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-20","filed_date":"2015-02-20","scope":"insider"},{"id":8653712,"accession":"0000908662-15-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-15-000009","line_url":"/filing/0000908662-15-000009","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":50.43083333333333,"price_display":"50.43","price_state":"stated","total_value":756462.5,"total_display":"756,462.50","total_whole":"756,463","shares_owned_after":510393.0,"shares_owned_after_display":"510,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-06","scope":"insider","n_lines":2},{"id":6173421,"accession":"0000908662-14-000302","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000908662-14-000302","line_url":"/filing/0000908662-14-000302","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.38768,"price_display":"45.39","price_state":"stated","total_value":680815.2,"total_display":"680,815.20","total_whole":"680,815","shares_owned_after":517938.0,"shares_owned_after_display":"517,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-02","scope":"insider","n_lines":3},{"id":6690766,"accession":"0000908662-14-000273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-14-000273","line_url":"/filing/0000908662-14-000273","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":42.5207904,"price_display":"42.52","price_state":"stated","total_value":637811.856,"total_display":"637,811.86","total_whole":"637,812","shares_owned_after":532561.0,"shares_owned_after_display":"532,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider","n_lines":2},{"id":6854516,"accession":"0000908662-14-000138","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000908662-14-000138","line_url":"/filing/0000908662-14-000138","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":39.16948266666667,"price_display":"39.17","price_state":"stated","total_value":587542.24,"total_display":"587,542.24","total_whole":"587,542","shares_owned_after":547038.0,"shares_owned_after_display":"547,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-02","scope":"insider","n_lines":3},{"id":6952408,"accession":"0000908662-14-000114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000908662-14-000114","line_url":"/filing/0000908662-14-000114","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.48671675,"price_display":"38.49","price_state":"stated","total_value":384867.1675,"total_display":"384,867.17","total_whole":"384,867","shares_owned_after":565638.0,"shares_owned_after_display":"565,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-12","scope":"insider","n_lines":3},{"id":6690762,"accession":"0000908662-14-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-14-000067","line_url":"/filing/0000908662-14-000067","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":38.099104568965515,"price_display":"38.10","price_state":"stated","total_value":220974.8065,"total_display":"220,974.81","total_whole":"220,975","shares_owned_after":571723.0,"shares_owned_after_display":"571,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-14","filed_date":"2014-02-14","scope":"insider","n_lines":2},{"id":7042705,"accession":"0000908662-14-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-14-000006","line_url":"/filing/0000908662-14-000006","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001571211","owner_name":"Luly Jay R.","owner_display_name":"Luly Jay R.","owner_url":"/insider/0001571211","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":28.0514674137931,"price_display":"28.05","price_state":"stated","total_value":162698.511,"total_display":"162,698.51","total_whole":"162,699","shares_owned_after":325189.0,"shares_owned_after_display":"325,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Director, Officer (President and CEO)","n_filings":18,"first_seen":"2014-01-03","last_seen":"2025-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001571211","retrieved_at":"2026-08-26T14:48:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}